Comparison Of Two Tablet Formulations Of SB-568859

Clinical trial NCT00470145 · COMPLETED

Trial details

NCT number: NCT00470145
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2007-04-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.